Dr. Qiang Xue represents clients in all aspects of antitrust law, including government investigations, merger reviews, and private litigations. His recent experience includes Bombardier Transportation’s acquisition by Alstom, PotashCorp’s merger-of-equals with Agrium, and high-profile investigations in the health care, semiconductor, internet platform, automobile, and banking industries. In addition, Qiang has extensive experience in antitrust enforcement and government regulation out of China. He recently assisted a major Chinese financial institution in a matter relating to a significant U.S. government investigation and a leading Chinese transportation company in defending a U.S. antitrust investigation.
Chinese court enforces mandatory licensing for "essential facility" patents in antitrust caseJones Day, Peter Wang, Qiang Xue, Yizhe Zhang, Haifeng Huang and Lawrence Wang, 15 June 2021, Insights